1. Home
  2. SRPT vs RCAT Comparison

SRPT vs RCAT Comparison

Compare SRPT & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • RCAT
  • Stock Information
  • Founded
  • SRPT 1980
  • RCAT 2002
  • Country
  • SRPT United States
  • RCAT United States
  • Employees
  • SRPT N/A
  • RCAT N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • RCAT Wholesale Distributors
  • Sector
  • SRPT Health Care
  • RCAT Industrials
  • Exchange
  • SRPT Nasdaq
  • RCAT Nasdaq
  • Market Cap
  • SRPT 1.9B
  • RCAT 1.5B
  • IPO Year
  • SRPT 1997
  • RCAT 2017
  • Fundamental
  • Price
  • SRPT $17.65
  • RCAT $9.22
  • Analyst Decision
  • SRPT Hold
  • RCAT Strong Buy
  • Analyst Count
  • SRPT 30
  • RCAT 2
  • Target Price
  • SRPT $35.93
  • RCAT $15.00
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • RCAT 11.0M
  • Earning Date
  • SRPT 11-03-2025
  • RCAT 12-15-2025
  • Dividend Yield
  • SRPT N/A
  • RCAT N/A
  • EPS Growth
  • SRPT N/A
  • RCAT N/A
  • EPS
  • SRPT N/A
  • RCAT N/A
  • Revenue
  • SRPT $2,413,715,000.00
  • RCAT N/A
  • Revenue This Year
  • SRPT $10.20
  • RCAT $883.03
  • Revenue Next Year
  • SRPT N/A
  • RCAT $110.60
  • P/E Ratio
  • SRPT N/A
  • RCAT N/A
  • Revenue Growth
  • SRPT 47.15
  • RCAT N/A
  • 52 Week Low
  • SRPT $10.42
  • RCAT $3.21
  • 52 Week High
  • SRPT $138.81
  • RCAT $16.70
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 38.30
  • RCAT 40.52
  • Support Level
  • SRPT $15.08
  • RCAT $9.52
  • Resistance Level
  • SRPT $18.80
  • RCAT $11.67
  • Average True Range (ATR)
  • SRPT 1.40
  • RCAT 0.93
  • MACD
  • SRPT -0.84
  • RCAT -0.33
  • Stochastic Oscillator
  • SRPT 24.92
  • RCAT 33.23

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

Share on Social Networks: